Literature DB >> 6317004

Sex steroid receptor proteins in foetal, adult and malignant human liver tissue.

M J Iqbal, M L Wilkinson, P J Johnson, R Williams.   

Abstract

Sex steroid receptor proteins were studied in human normal liver and hepatocellular carcinoma (HCC). Oestrogen receptor (ER) was detected in nucleosol and cytosol of 4 normal adult and 5 malignant liver specimens and in the cytosol of 6 foetal liver samples. Levels were 27.6-500 fmol mg-1 soluble protein in normal adults (Kd 1.48 X 10(-8) -1.12 X 10(-10) mol 1(-1) ), 45-290 fmol mg-1 in malignant liver tissue (Kd 3.26 X 10(-9) -3.64 X 10(-10) mol 1(-1] and a mean of 93 fmol mg-1 in foetal tissue (Kd 1.55 X 10(-9) mol 1(-1]. Androgen receptors (AR) were found only in cytosol and nucleosol of HCC (23-370 fmol mg-1) and in cytosol from foetal liver (29 fmol mg-1) with Kd from 2.90 X 10(-9) to 3.734 X 10(-10) mol 1(-1]. AR was distinguished from sex hormone binding globulin, which was also present in all cytosol samples, by the former's ability to selectively bind to methyltrienolone and the latter's absence from nucleosol. These findings provide further support for suggestions that oestrogen-related hepatic functions in man may be mediated by receptors and raise the possibility that hepatocellular carcinoma may be androgen dependent.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6317004      PMCID: PMC2011561          DOI: 10.1038/bjc.1983.268

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  26 in total

1.  Scatchard plots: common errors in correction and interpretation.

Authors:  G C Chamness; W L McGuire
Journal:  Steroids       Date:  1975-10       Impact factor: 2.668

Review 2.  Hepatic tumors: possible relationship to use of oral contraceptives.

Authors:  G Klatskin
Journal:  Gastroenterology       Date:  1977-08       Impact factor: 22.682

3.  A study of the androgen receptors in a variety of androgen-sensitive tissues.

Authors:  W I Mainwaring; F R Mangan
Journal:  J Endocrinol       Date:  1973-10       Impact factor: 4.286

4.  Binding and metabolism of testosterone and of 5-dihydrotestosterone in bulbocavernous/levator ani (BCLA) of male rats: in vivo and in vitro studies.

Authors:  M Krieg; R Szalay; K D Voigt
Journal:  J Steroid Biochem       Date:  1974-08       Impact factor: 4.292

5.  Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma.

Authors:  F L Johnson; K G Lerner; M Siegel; J R Feagler; P W Majerus; J R Hartmann; E D Thomas
Journal:  Lancet       Date:  1972-12-16       Impact factor: 79.321

6.  An improved method for the study of high-affinity steroid binding:-oestradiol binding in brain and pituitary.

Authors:  M Ginsburg; B D Greenstein; N J MacLusky; I D Morris; P J Thomas
Journal:  Steroids       Date:  1974-06       Impact factor: 2.668

7.  Selective retention of dihydrotestosterone by prostatic nuclei.

Authors:  K M Anderson; S Liao
Journal:  Nature       Date:  1968-07-20       Impact factor: 49.962

8.  The binding of (1,2-3H)testosterone within nuclei of the rat prostate.

Authors:  W I Mainwaring
Journal:  J Endocrinol       Date:  1969-07       Impact factor: 4.286

9.  Estrogen receptor in the mammalian liver.

Authors:  A J Eisenfeld; R Aten; M Weinberger; G Haselbacher; K Halpern; L Krakoff
Journal:  Science       Date:  1976-02-27       Impact factor: 47.728

10.  Prostatic distribution of sex hormone-binding globulin and cortisol-binding globulin in benign hyperplasia.

Authors:  R A Cowan; S K Cowan; C A Giles; J K Grant
Journal:  J Endocrinol       Date:  1976-10       Impact factor: 4.286

View more
  17 in total

Review 1.  Hepatocellular carcinoma. A worldwide problem and the major risk factors.

Authors:  R G Simonetti; C Cammà; F Fiorello; F Politi; G D'Amico; L Pagliaro
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

Review 2.  Advances in neoplastic disease of the liver and biliary tract.

Authors:  P J Johnson; M L Wilkinson; J Karani
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

3.  Human hepatocellular carcinoma tumor xenografts. Their androgen-receptor status and growth responses to castration.

Authors:  A A Dunk; N Kyprianou; P Davies; H C Thomas
Journal:  Dig Dis Sci       Date:  1988-04       Impact factor: 3.199

4.  Androgen receptor in hepatocellular carcinoma as a prognostic factor after hepatic resection.

Authors:  N Nagasue; Y C Chang; T Hayashi; G Galizia; H Kohno; T Nakamura; H Yukaya
Journal:  Ann Surg       Date:  1989-04       Impact factor: 12.969

5.  Suppressive effect of oestradiol on chemical hepatocarcinogenesis in rats.

Authors:  I Shimizu; M Yasuda; Y Mizobuchi; Y R Ma; F Liu; M Shiba; T Horie; S Ito
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

6.  In vitro screening of environmental chemicals for targeted testing prioritization: the ToxCast project.

Authors:  Richard S Judson; Keith A Houck; Robert J Kavlock; Thomas B Knudsen; Matthew T Martin; Holly M Mortensen; David M Reif; Daniel M Rotroff; Imran Shah; Ann M Richard; David J Dix
Journal:  Environ Health Perspect       Date:  2010-04       Impact factor: 9.031

7.  Hepatitis C virus core protein augments androgen receptor-mediated signaling.

Authors:  Tatsuo Kanda; Robert Steele; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

8.  Quantitation of estrogen and androgen receptors in hepatocellular carcinoma and adjacent normal human liver.

Authors:  P K Eagon; A Francavilla; A DiLeo; M S Elm; L Gennari; V Mazzaferro; G Colella; D H Van Thiel; T E Strazl
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

Review 9.  Hepatitis B virus infection and primary hepatocellular carcinoma.

Authors:  M Feitelson
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

Review 10.  Role of sex steroid receptors in pathobiology of hepatocellular carcinoma.

Authors:  Mamta Kalra; Jary Mayes; Senait Assefa; Anil-K Kaul; Rashmi Kaul
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.